Wilm's Tumor 1 (WT1) Peptide Vaccination for Patients With High Risk Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00433745

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:40.212515+00:00

Published At

2014-07-08T00:00:00+00:00

Record Updated At

2014-07-08

Results Posted At

2014-07-08

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Myelodysplastic Syndrome", "Acute Myeloid Leukemia (AML)", "Chronic Myeloid Leukemia (CML)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-07-08"

protocolSection.identificationModule.nctId

"NCT00433745"

protocolSection.identificationModule.officialTitle

"Wilm\u0027s Tumor 1 (WT1) Peptide Vaccination for Patients With High Risk Hematological Malignancies"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2014-07-08"

Study condition terms

• Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
• Chronic Myeloid Leukemia (CML) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.